Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis

NCT00477971 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

89

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL: filgrastim
DRUG: dexamethasone
DRUG: melphalan
PROCEDURE: autologous hematopoietic stem cell transplantation

Sponsor

Mayo Clinic

Collaborators

[object Object]